Valera Pharmaceuticals Inc Stock Analysis
Technical stock analysis for 23 January 2019
Valera Pharmaceuticals Inc fell by -1.69% in the last day from $0.41 to $0.40 The price has fallen in 7 of the last 10 days and is down by -4.67% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -336 041 shares and in total 514 591 shares bought and sold for approximately $206 968.00.
Close price at the end of the last trading day (Wednesday, 23rd Jan 2019) of the VLRX stock was $0.40. This is 1.69% less than the trading day before Tuesday, 22nd Jan 2019.
During day the stock fluctuated 6.30% from a day low at $0.40 to a day high of $0.42.
30 day high of the VLRX stock price was $0.45 and low was $0.30.
90 day high was $1.27 and low was $0.30.
52 week high for the Valera Pharmaceuticals Inc - $4.58 and low - $0.30.
Valera Pharmaceuticals Inc lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.53 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -60.54% during the next 3 months and, with 90% probability hold a price between $-0.06 and $0.21 at the end of this period.
Valera Pharmaceuticals Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $0.41. On a fall, the stock will find some support from the long-term average at approximately $0.37. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday January 08, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
The stock holds a RSI14 at 77 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
Valera Pharmaceuticals Inc finds support from accumulated volume at $0.40.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 6.30%. For the last week the stock has had a daily average volatility of 6.34%.
The stock is overbought on RSI14 and lies in the upper part of the trend. Normally this will pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stoploss: $0.38 (-5.65%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 77 and this increases the risk substantially. There is a sell signal from pivot top found 10 days ago.)
Very Low Low Medium High Very High
Valera Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|VLRX $0.40 $-0.01(-1.69%)|
VLRX is down $0.01 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for VLRX based on the 1-3 month system that more than doubles the S&P 500.
Click here – the VLRX analysis is free »